Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-69
SponsorOhio State University Comprehensive Cancer Center

About this trial

This clinical trial identifies the needs and preferences of rural stage I-III postmenopausal breast and endometrial cancer survivors and evaluates the impact of an adaptive, online program, mobile (m)Health + ecological momentary assessment (EMA) intervention, on lifestyle modification and their weight loss efforts. Obesity, a condition marked by an abnormally high, unhealthy amount of body fat, is associated with lower physical and psychological well-being, higher risk of recurrence, and higher cancer-specific and all-cause mortality (number of deaths). Lifestyle factors, such as low physical activity and unhealthy diet, are the main contributors to obesity that are modifiable. Lifestyle weight loss programs focusing on modifiable factors can improve cancer-specific survival and many aspects of health, but access to these programs can be challenging in rural settings. A remote lifestyle program, adapted to individual goals and needs, may help promote healthy behaviors, improve cancer outcomes, and reduce disease burden in stage I-III postmenopausal breast and endometrial cancer survivors.

Eligibility criteria

Qualifiers

Body mass index (BMI) ≥ 25kg/m²

Age: 40-69 years

1-5 years post-diagnosis of stage I-III postmenopausal breast cancer or stage I-III endometrial cancer

No known evidence of recurrence (local or distant) or second, primary cancer

Disqualifiers

Severe medical conditions, such as unstable cardiovascular disease or digestive disorders, that would preclude physical activity and dietary intervention

Lack of physician clearance if determined necessary by the Physical Activity Readiness Questionnaire (PAR-Q+)

Acute physical limitations for unsupervised exercises at home

Unable to give informed consent

Trial design

Treatments tested in this trial

  • Aerobic Exercise
  • Biospecimen Collection
  • Dietary Intervention
  • Discussion
  • Goal Setting
  • Internet-Based Intervention
  • Medical Device Usage and Evaluation
  • Questionnaire Administration
  • Resistance Training
  • Smartphone Application-based Intervention
  • Supportive Care
  • Supportive Care
  • Tailored Intervention

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ohio State University Comprehensive Cancer Center

Lead sponsor

American Association for Cancer Research

Collaborator